Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Novel Antibody-Based Protection/Therapeutics in Staphylococcus aureus.
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.
Reshaping lipid metabolism with long-term alternate day feeding in type 2 diabetes mice.
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion.
Principal Investigator
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Dolan, Mary
contributes to
Genetic determinants associated with pemetrexed response and toxicity